RET and melanoma: We measured the frequency of M- and PMN-MDSC in melanoma lesions (primary skin tumor and metastatic lymph nodes (LN)), the peripheral blood, spleen and bone marrow (BM) by flow cytometry, using the RET transgenic mouse model, which mimics the human situation (Figure S1).